Saiid Zarrabian's Net Worth
-$84 Thousand
Who is Saiid Zarrabian?
Saiid Zarrabian does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kintara Therapeutics, Inc., LA JOLLA PHARMACEUTICAL CO, and PENWEST PHARMACEUTICALS CO.
SEC CIK
Saiid Zarrabian's CIK is 0001495521
Past Insider Trading and Trends
2017 was Saiid Zarrabian's most active year for acquiring shares with 5 total transactions. Saiid Zarrabian's most active month to acquire stocks was the month of March. 2013 was Saiid Zarrabian's most active year for disposing of shares, totalling 2 transactions. Saiid Zarrabian's most active month to dispose stocks was the month of August. 2017 saw Saiid Zarrabian paying a total of $50,056.00 for 416,900 shares, this is the most they've acquired in one year. In 2013 Saiid Zarrabian cashed out on 29,268,390 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kintara Therapeutics, Inc. (KTRA) Snapshot price: $0.1146
Head Strategic PartnershipsSaiid Zarrabian owns 61,400 units of Common Stock which is worth $7,036.44. From 2017 to 2021 Saiid Zarrabian acquired a total of 110,900 shares in Kintara Therapeutics, Inc. at a cost of $81,372.37.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +909.09% | 50K |
$0.63 | $31,316.37 | 55.5K |
Dec 6 - Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
∞
| 60.9K |
$0.83 | $50,056.00 | 60.9K |
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LA JOLLA PHARMACEUTICAL CO No price found
InvestorSaiid Zarrabian owns 5,462,276 units of Common Stock. From 2012 to 2015 Saiid Zarrabian acquired a total of 15,823,168 shares in LA JOLLA PHARMACEUTICAL CO at a cost of $9,617.43, Saiid also disposed a total of 10,360,892 shares of LA JOLLA PHARMACEUTICAL CO.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +80.58% | 307 |
$19.50 | $5,986.50 | 688 |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 381 |
$9.53 | $3,630.93 | 381 |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 4
| -53.88% | -6.38M |
—
|
—
| 5.46M |
Sep 24
| |||
Form 4
| +25.41% | 300K |
—
|
—
| 1.48M |
Apr 29
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 10
| |||
Form 4
|
∞
| 11.54M |
—
|
—
| 11.54M |
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PENWEST PHARMACEUTICALS CO No price found
InvestorSaiid Zarrabian used to own units in Common Stock but no longer holds any shares there. In the year 2010 Saiid Zarrabian filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -20.00K |
—
|
—
|
0
|
Sep 20
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||